Successful management of microscopic residual disease in large bowel cancer.
about
Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancerOutcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry.Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alonePeritoneal carcinomatosis of gastrointestinal tumors: where are we now?Review article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.Peritoneal carcinomatosis of colorectal origin.Intraperitoneal chemotherapy for colorectal cancer.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.New responsibilities in the management of colorectal cancer with peritoneal seeding.Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasmsManagement of renal extraskeletal mesenchymal chondrosarcomaApplication of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center.Carcinomatosis from gastrointestinal cancer.Polycyclic aromatic hydrocarbons in electrocautery smoke during peritonectomy procedures.Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patientsSiRNA-mediated reduction of alpha-actinin-1 inhibits pressure-induced murine tumor cell wound implantation and enhances tumor-free survivalCecum cancer underlying appendicular abscess. Case report and review of literature.Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites.Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy.Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent Epithelial Ovarian Cancer: Results from a Retrospective Study on Prospectively Established DatabaseLaboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy.Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of beta1-integrin at threonine 788/789Evolving management of colorectal cancer.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.Current status and future directions: management of colon cancer with peritoneal dissemination.Surgical management of carcinomatosis from colorectal cancer.Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.Surgical management of colorectal peritoneal metastases: treatment and outcomes compared with hepatic metastases.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.Surgical treatment of peritoneal carcinomatosis: current treatment modalities.Peritoneal cancer treatment.
P2860
Q24556616-A8DD5517-1167-4D43-82D6-548332A595F2Q30581570-13C0EF53-95C9-450A-A13B-9C53B48DCBB4Q33457159-87CABCF6-E1C6-40CE-9F89-94C9AAE302E7Q33988091-D413BB6A-7BF4-4D73-8B35-149C698E4EF1Q33994410-3E2B5D17-B07B-4B33-9CF9-5AC78FFB65CEQ34015030-20493F3E-76A9-4B5B-8A09-76DEA33EF03FQ34258723-37FB48F1-2D27-441A-96E8-111A9654D641Q34326741-DD748AEC-F42D-4F22-8097-A52BDCE5C9E6Q34354500-F0DF524D-EA9A-4119-8182-15545717C920Q34366940-D0B4D5A5-3371-4E10-8DCA-D66CAA822949Q34374142-CD092823-CE2F-4EE5-AD33-1F3D7A022315Q34390124-94A1B11E-A399-4717-B63F-EAFA8848C1A4Q34391090-3E9810E9-99A0-4599-8E47-8B35697431C9Q34469122-2CFE087B-8618-477B-8323-A7AD23B1FE9EQ34819493-ECD724E2-EE50-4490-9A68-F51965F381FFQ34928467-7DC8A31C-7492-4EA7-A3EB-EDA5401D893EQ35008339-D18202AA-D405-488C-8455-2A2E8691CC33Q35445073-B0226B5E-F1D2-44EC-B4DC-53D47FCEED64Q35522658-8B9417B4-927E-4E28-99DB-78B82F24997BQ35628212-A47A224B-B15D-4D67-9058-E377984AD445Q35682209-D50C5C1A-B456-465C-9DE9-6657CA5D25A9Q35999900-52E11B7F-2057-49E0-9475-51CA6D4910D6Q36063487-798D264A-EB95-4B62-BBA7-F501680659E1Q36485279-1C83B7FD-5D66-4D13-8B38-FD6A1BC6E2B4Q36499300-2D967036-2614-46B3-A0FD-119DF1586764Q36628679-C9C97541-A047-47C7-9795-3771A539974BQ36758912-8B643F96-6951-43C7-86A8-6CDE8C87F736Q36804710-A367696C-7F36-49BF-ACA1-323207D63639Q36911440-634634BD-098E-4526-99E6-88FD7D9D6DFCQ37086489-E64299F7-EF42-4767-8400-879284C3BC90Q37210172-5336A2CB-C11D-40FB-8E37-6DD1172D2EBFQ37260591-20962C66-4CAD-4164-9122-F685C78E888EQ37298660-EBD68ECA-594D-490E-A7CF-C99519416FE0Q37427509-7C945EBC-A899-4734-9DE8-199DB2F02CF0Q37987561-7C948FDE-EF9F-4694-B3F2-AB1EEFD6A6F6Q38058707-ADE141E2-48F4-4948-8B00-7DF9CF4988BBQ38090517-264F03DB-94C9-481E-9636-222D839FCD88Q38112342-3067FF4A-4966-41B4-80FC-3EA83C23F9F7Q38163913-F4B1A835-16D8-4B41-ABF4-67A9D27A71E5Q38195114-E8C6B1EC-1963-4DAF-BF98-3F0A6BF9C59D
P2860
Successful management of microscopic residual disease in large bowel cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Successful management of microscopic residual disease in large bowel cancer.
@ast
Successful management of microscopic residual disease in large bowel cancer.
@en
type
label
Successful management of microscopic residual disease in large bowel cancer.
@ast
Successful management of microscopic residual disease in large bowel cancer.
@en
prefLabel
Successful management of microscopic residual disease in large bowel cancer.
@ast
Successful management of microscopic residual disease in large bowel cancer.
@en
P356
P1476
Successful management of microscopic residual disease in large bowel cancer.
@en
P2093
Sugarbaker PH
P2888
P304
P356
10.1007/S002800051093
P478
P577
1999-01-01T00:00:00Z
P6179
1049559447